Background Image
Table of Contents Table of Contents
Previous Page  64 / 72 Next Page
Information
Show Menu
Previous Page 64 / 72 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016

118

AFRICA

30. Myerson S, Mitchell A, Ormerod O, Banning A. What is the role of

balloon dilatation for severe aortic stenosis during pregnancy?

J Heart

Valve Dis

2005;

14

(2): 147–150.

31. Hameed AB, Mehra A, Rahimtoola SH. The role of catheter balloon

commissurotomy for severe mitral stenosis in pregnancy.

Obstet Gynecol

2009;

114

(6): 1336–1340.

32. Baumgartner H, Bonhoeffer P, De Groot N, de Haan F, Deanfield J,

Galie N,

et al

. Association for European Paediatric Cardiology (AEPC);

ESC Committee for Practice Guidelines (CPG). ESC Guidelines for the

management of grown-up congenital heart disease (new version 2010).

Eur Heart J

2010;

31

(23): 2915–2957.

33. Bhargava B, Agarwal R, Yadav R, Bahl VK, Manchanda SC.

Percutaneous balloon aortic valvuloplasty during pregnancy: use of

the Inoue balloon and the physiologic antegrade approach.

Catheteriz

Cardiovasc Diag

1998;

45

(4): 422–425.

34. Regitz-Zagrosek V, Lundqvist CB, Borghi C, Cifkova R, Ferreira R,

Foidart J-M,

et al

. ESC Guidelines on the management of cardiovascu-

lar diseases during pregnancy.

Eur Heart J

2011;

32

: 3147–3197.

35. Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart

disease.

Lancet

2012;

379

(9819): 953–964.

36. Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: pros-

thetic valves.

J Am Coll Cardiol

2005;

46

(3): 403–410.

37. Ginsberg JS, Hirsh J. Anticoagulants during pregnancy.

A Rev Med

1989;

40

(1): 79–86.

38. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted

doses of subcutaneous heparin to prevent thromboembolic phenomena

in pregnant patients with mechanical cardiac valve prostheses.

J Am Coll

Cardiol

1996;

27

(7): 1698–1703.

39. Elkayam U, GolandS. The search for a safe and effective anticoagulation

regimen in pregnant women with mechanical prosthetic heart valves.

J

Am Coll Cardiol

2012;

59

(12): 1116–1118.

40. Warnes CA, Scott ML, Silver GM, Smith CW, Ferrans VJ, Roberts WC.

Comparison of late degenerative changes in porcine bioprostheses in

the mitral and aortic valve position in the same patient.

Am J Cardiol

1983;

51

(6): 965–968.

41. Yun KL, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB,

et

al

. Durability of the Hancock MO bioprosthesis compared with stand-

ard aortic valve bioprostheses.

Ann Thorac Surg

1995;

60

: S221–S228.

42. Mazibuko B, Ramnarain H, Moodley J. An audit of pregnant women

with prosthetic heart valves at a tertiary hospital in South Africa: a five-

year experience.

Cardiovasc J Afr

, 2012;

23

(4): 216–221.

43. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier L-A, Morton BC,

et al

. Prospective multicenter study of pregnancy outcomes in women

with heart disease.

Circulation

2001;

104

(5): 515–521.

44. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascu-

lar disease in pregnancy: a systematic overview from 1978 through 1996.

J Am Coll Cardiol

1998;

31

(7): 1650–1657.

45. Bédard E, Dimopoulos K, Gatzoulis MA. Has there been any progress

made on pregnancy outcomes among women with pulmonary arterial

hypertension?

Eur Heart J

2009;

30

(3): 256–265.

46. Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame

JE,

et al.

World Health Organization Pulmonary Hypertension group

2: pulmonary hypertension due to left heart disease in the adult – a

summary statement from the Pulmonary Hypertension Council of the

International Society for Heart and Lung Transplantation.

J Heart Lung

Transplant

2012;

31

(9): 913–933.

47. Kiely D, Condliffe R, Webster V, Mills G, Wrench I, Gandhi S,

et al

.

Improved survival in pregnancy and pulmonary hypertension using

a multiprofessional approach.

Br J Obstet Gynaecol

2010;

117

(5):

565–574.

48. Karthikeyan G, Zühlke L, Engel M, Rangarajan S, Yusuf S, Teo K,

et

al

. Rationale and design of a Global Rheumatic Heart Disease registry:

the REMEDY study.

Am Heart J

2012;

163

(4): 535–540.

49. Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A,

et

al

. Trends in infective endocarditis incidence, microbiology, and valve

replacement in the United States from 2000 to 2011.

J Am Coll Cardiol

2015;

65

(19): 2070–2076.

50. Nishimura RA, Carabello BA, Faxon DP, Freed MD, Lytle BW,

O’Gara PT,

et al

. ACC/AHA 2008 guideline update on valvular heart

disease: focused update on infective endocarditis: a report of the

American College of Cardiology/American Heart Association Task

Force on Practice Guidelines endorsed by the Society of Cardiovascular

Anesthesiologists, Society for Cardiovascular Angiography and

Interventions, and Society of Thoracic Surgeons.

J Am Coll Cardiol

2008;

52

(8): 676–685.

51. Tan JY-L. Cardiovascular disease in pregnancy. Obstet Gynaecol

Reprod Med 2007;

17

(5): 131–139.

52. Swan L, Lupton M, Anthony J, Yentis SM, Steer PJ, Gatzoulis MA.

Controversies in pregnancy and congenital heart disease.

Congenital

Heart Dis

2006;

1

(1–2): 27–34.